ASX - Delayed Quote AUD

Little Green Pharma Ltd (LGP.AX)

Compare
0.1450 -0.0100 (-6.45%)
At close: 4:10 PM GMT+11
Currency in AUD All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
6/30/2021
6/30/2020
Total Revenue
25,631.8300
25,631.8300
19,567.8580
7,003.6300
2,204.0210
Cost of Revenue
12,513.4610
12,513.4610
7,590.2460
1,227.8580
1,051.0510
Gross Profit
13,118.3690
13,118.3690
11,977.6120
5,775.7720
1,152.9700
Operating Expense
25,361.2340
25,361.2340
25,459.2570
10,673.7120
8,749.0270
Operating Income
-12,242.8650
-12,242.8650
-13,481.6450
-4,897.9400
-7,596.0570
Net Non Operating Interest Income Expense
-464.4120
-464.4120
-879.9210
-52.2550
-352.9740
Other Income Expense
1,475.8400
1,475.8400
2,746.4210
28,868.4840
-1,366.4040
Pretax Income
-8,152.5580
-8,152.5580
-8,556.6510
24,603.5550
-9,315.4350
Net Income Common Stockholders
-8,152.5580
-8,152.5580
-9,205.4290
24,603.5550
-9,315.4350
Basic EPS
-0.03
--
-0.04
0.16
-0.07
Diluted EPS
-0.03
--
-0.04
0.15
-0.07
Basic Average Shares
299,574.6570
--
249,835.3400
153,720.0920
127,945.5140
Diluted Average Shares
299,574.6570
--
249,835.3400
165,792.1500
127,945.5140
Net Income from Continuing & Discontinued Operation
-8,152.5580
-8,152.5580
-9,205.4290
24,603.5550
-9,315.4350
Normalized Income
-8,135.6490
-8,135.6490
-8,556.6510
24,603.5550
-9,315.4350
Interest Income
171.0570
171.0570
48.9180
39.2870
47.0610
Interest Expense
602.4260
602.4260
921.3060
91.5420
327.3690
Net Interest Income
-464.4120
-464.4120
-879.9210
-52.2550
-352.9740
EBIT
-7,550.1320
-7,550.1320
-7,635.3450
24,695.0970
-8,988.0660
EBITDA
-4,471.2530
-4,471.2530
-4,576.8510
25,380.3630
-8,801.8290
Reconciled Cost of Revenue
12,513.4610
12,513.4610
7,590.2460
1,227.8580
1,051.0510
Reconciled Depreciation
3,078.8790
3,078.8790
3,058.4940
685.2660
186.2370
Net Income from Continuing Operation Net Minority Interest
-8,152.5580
-8,152.5580
-8,556.6510
24,603.5550
-9,315.4350
Total Unusual Items Excluding Goodwill
-16.9090
-16.9090
--
--
--
Total Unusual Items
-16.9090
-16.9090
--
--
--
Normalized EBITDA
-4,454.3440
-4,454.3440
-4,576.8510
25,380.3630
-8,801.8290
6/30/2020 - 2/19/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers